HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PF 00477736

a Chk1 inhibitor; structure in first source
Also Known As:
PF-00477736; PF-477736; PF00477736; PF477736
Networked: 11 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ando, Kiyohiro: 2 articles (01/2020 - 07/2019)
2. Koshinaga, Tsugumichi: 2 articles (01/2020 - 07/2019)
3. Makishima, Makoto: 2 articles (01/2020 - 07/2019)
4. Nagase, Hiroki: 2 articles (01/2020 - 07/2019)
5. Wada, Satoshi: 2 articles (01/2020 - 07/2019)
6. Cázares-Ordoñez, Verna: 1 article (01/2020)
7. Kamijo, Takehiko: 1 article (01/2020)
8. Kobayashi, Shinichi: 1 article (01/2020)
9. Suenaga, Yusuke: 1 article (01/2020)
10. Yokoyama, Atsushi: 1 article (01/2020)

Related Diseases

1. Neoplasms (Cancer)
2. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
3. Neuroblastoma
4. Triple Negative Breast Neoplasms
5. Leukemia

Related Drugs and Biologics

1. Vemurafenib
2. Gemcitabine
3. 3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamide
4. Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
5. Carboplatin (JM8)
6. Proteins (Proteins, Gene)
7. Phenobarbital (Luminal)
8. DNA (Deoxyribonucleic Acid)
9. Dihydroorotate Dehydrogenase
10. Docetaxel (Taxotere)